Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Skip to article

Rheumatology in Perspective · A RheumaView publication

MEDICINES · A QUESTION WORTH EXPLAINING

Why Isn’t My New Medicine Working Yet?

Quick guideOpen to everyone · No registration
Waiting for a slow medicine, as it often feels from the inside.

Three weeks ago you started methotrexate. Your prednisone dose is coming down on schedule, your knuckles have noticed, and you are beginning to suspect that the new medicine is a dud. It almost certainly isn’t. It simply hasn’t had its turn yet.

Two kinds of medicine

Rheumatology relies on two groups of drugs that keep very different hours.

The fast group includes the anti-inflammatory painkillers known as NSAIDs (naproxen, ibuprofen) and the glucocorticoids, usually just called steroids (prednisone). They work within hours or days by calming inflammation that is already there. The disease process underneath carries on largely undisturbed, so when these drugs are stopped the symptoms tend to come back.

The slow group is called DMARDs, short for disease-modifying antirheumatic drugs. Methotrexate, hydroxychloroquine, sulfasalazine and leflunomide belong here, along with the biologics and the newer targeted pills. They act further upstream, on the immune activity that drives the disease, which is how they protect joints and organs over years. Working upstream takes time, and most people feel nothing for weeks.

Why you were given both

A DMARD started alone would leave inflammation unchecked for the whole waiting period. So a fast drug is often added to cover the interval. Doctors call this bridging: the steroid holds things steady while the DMARD gathers strength, and then the steroid is reduced and stopped.

The awkward part is the middle. The steroid dose is falling, the DMARD has not fully arrived, and for a few weeks you may feel worse than you did a month ago. Nearly everyone reads this as failure. In most cases it is timing.

A sketch of the idea, not a measurement. The fast drug rises early and is tapered; the DMARD arrives later and stays. The shaded gap is where most doubts begin.

How long is slow?

It depends on the drug. Methotrexate usually needs 6 to 12 weeks. Hydroxychloroquine can take 2 to 6 months and would lose a race to most houseplants. Many biologics show something within 2 to 12 weeks. Your rheumatologist can tell you the expected window for yours, and it is worth asking on the day the prescription is written.

Why switching early costs you

A DMARD can be judged only after enough time at a sufficient dose. If you stop at week four you have learned nothing about it, and yet it may go into your chart as a drug that “didn’t work.” The list of available treatments is long, but it does end, and each option deserves an honest trial before it is crossed off.

Waiting has limits too. If nothing at all has improved by about three months, or the agreed goal has not been reached by about six, the plan should change. Side effects are a separate matter and a reason to call sooner, since many of them can be fixed without giving up the drug.

The opposite mistake

Feeling well on a DMARD usually means the DMARD is working. Many people stop it at exactly that point, and the flare that follows may arrive two or three months later, long after anyone connects it to the missing pills.

Four questions for your next visit

  • When will we judge whether this medicine is working?
  • What will count as working?
  • What should I do if I feel worse before then?
  • What is the next step if it doesn’t work?

This article is general education. It does not replace advice from your own physician, who knows your diagnosis, your other medicines and your test results.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: How treatment worksMedication guideMedication safetyTreatmentTreatment decisions